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Abstract 
Diffuse and reactive pituitary gland 
enlargement secondary to primary 
hypothyroidism is an uncommon 
occurrence and that can masquerade many 
pituitary disorders. In present article, we 
report a case of 19 year female severe 
hypothyroidism presenting with diffuse 
enlargement of pituitary gland and 
hyperprolactinemia and review the clinical 
importance of this entity. Knowledge of 
this entity is very important to avoid 
unnecessary surgery and irreversible 
complications in this sub-group of patients. 
Key words: Pituitary hyperplasia, 
primary hypothyroidism, pituitary 
hyperplasia. 
Introduction 
Diffuse and reactive pituitary gland 
enlargement secondary to primary 
hypothyroidism is an uncommon 
occurrence and that can masquerade many 
pituitary disorders. (1-8) In present article, 
we report a case of severe hypothyroidism 
presenting with diffuse enlargement of 
pituitary gland and hyperprolactinemia. 
Case report 
A 19 year female presented with 
headache of one year duration and one 
episode of seizures. There was history of 
galactorrhoea. There was no history of loss 
of appetite and cold intolerance. She had 
easy fatigability and no visual symptoms. 
Her general and systemic examination was 
unremarkable. Higher mental functions 
and cranial nerves were normal. Motor and 
sensory examination was normal. Deep 
tendon reflexes were sluggish. Routine 
blood investigations were within normal 
range, except low level of hemoglobin (9.1 
gm / dL). Hormonal profile revealed raised 
thyrotropin stimulating hormone (TSH) 
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(>100 microlU/dL, range 0.34-5.6) and low 
T4 (0.10 microgram/mL, range 0.61-1.12). 
Prolactin was 200 IU/dL. Magnetic 
resonance imaging (MRI) of the brain 
showed a large diffuse sellar mass lesion, 
hypointense on T1W images and 
uniformly enhancing after contrast 
administration (Figure 1 and 2). Based on 
clinical features, investigation reports 
(increased TSH and prolactin secretion) 
and imaging findings  a diagnosis of 
diffuse pituitary hyperplasia secondary to 
primary hypothyroidism was made. The 
patient was started on 100 microgram 
thyroxine.  
Discussion 
Pituitary hyperplasia is a process and 
ranges from the slight increase in the 
number of normal cells without much 
change in the tissue architecture to massive 
enlargement of the gland with significant 
alteration in both tissue architecture and 
morphology. (9) Thyrotroph hyperplasia is 
the most common cause of pituitary 
enlargement in the context of untreated 
primary hypothyroidism. (2, 10) The 
incidence of pituitary hyperplasia in 
hypothyroidism ranges from 25% to 81% 
(11) and the incidence is high if the TSH 
levels are >50 microIU/mL. (12) It has 
been suggested that the primary 
uncontrolled hypothyroidism can be a 
precursor to pituitary hyperplasia. (2) Low 
thyroxine levels in these patients results in 
the loss of negative control on 
hypothalamo-pituiatry-thyroid axis 
resulting in the increase of thyrotroph 
releasing hormone (TRH) from 
hypothalamus which increases the thyroid 
stimulating hormone (TSH) from pituitary 
in an attempt to maintain the normal 
thyroxine levels (3, 7, 13-16) 
 
 
Figure 1 
MRI brain axial images showing diffuse 
enlargement of the pituitary gland, it was 
hypointense on T1W images and diffusely 
enhancing after contrast administration 
 
 
Figure 2 
MRI brain sagittal and coronal post-contrast images 
showing diffusely enhancement of pituitary gland 
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As was seen in present case, TRH also 
exerts a weak stimulatory effect on 
lactotroph cells resulting in mild to 
moderate hyperprolactinemia is expected. 
(13) Because TRH also has a weak 
stimulatory effect on lactotroph cells, mild 
to moderate hyperprolactinemia may also 
occur in about three-quarters of patients. 
(11)  Clinically the patients with pituitary 
hyperplasia can present with headache, 
visual symptoms and features of 
hypothyroidism. (1, 3, 7, 14) It is 
important to understand that the headache 
may be due to hypothyroidism, although 
the exact underlying mechanism is not 
clear. (7) In many cases pituitary 
hyperplasias may be clinically silent and 
focal pituitary hyperplasia can be an 
incidental finding at autopsy.  9 The 
diagnosis of pituitary hyperplasia can be 
difficult and it needs a high degree of 
clinical suspicion. (1-4, 6-8, 11, 12, 14, 15, 
17) Radiological investigations i.e. CT and 
MRI with contrast administration will 
show the enlargement of pituitary gland. 
MRI is superior to CT scan and a follow 
up imaging will further help to monitor 
the size of the gland.  (4, 6, 18-22) Detail 
thyroid functions are the mainstay of 
diagnosis as it will show decrease in the 
levels of serum T3 and T4 but greatly 
elevated serum TSH levels. (2, 3, 6) One 
the diagnosis of pituitary hyperplasia 
secondary to primary hypothyroidism is 
suspected the patients can be managed 
with adequate hormone replacement with 
L-thyroxine (25 to 300 mcg/day) and in 
most of the cases this will result in relief of 
symptoms and regression of pituitary 
hyperplasia within a few months. (1-4, 6-8, 
11, 12, 14, 15, 17) In a selected group of 
patients where there is compression of the 
optic chiasm, does not respond to, or 
worsens under, thyroid hormone 
replacement or the diagnosis is in doubt 
surgery may be considered as an option. 
(23) Although imaging findings will not 
distinguish between TSH-producing 
macroadenoma and hyperplasia of 
pituitary gland, only the follow up imaging 
and response to replacement therapy will 
support the diagnosis.  (24) 
Conclusion 
In summary, diffuse pituitary 
enlargement can be a manifestation of 
severe primary hypothyroidism and 
interpretation of a pituitary mass without 
an endocrine investigation can lead to 
unnecessary surgery (4, 5, 22, 25, 26). A 
knowledge of this entity is very important 
to avoid unnecessary surgery and 
irreversible complications in this sub-group 
of patients. 
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